Monday, November 13, 2017 9:52:27 AM
File one or more patent applications in Q4 2017
Initiate activities for GMP manufacturing of LADRTM linkers in Q4
2017
Nominate one or more candidates for advancement into IND
enabling studies in Q1 2018
Present preclinical data on LADRTM conjugates at a scientific
meeting in the first half of 2018
Request pre
-
IND meeting with the FDA in the first half of 2018
?
Begin partnering discussions for high potency LADR
TM
conjugates
in
first half of 2018
?
File first IND for LADR conjugate in second half of 2018
https://cytrxcorporation.gcs-web.com/static-files/bf7ec85c-f083-4a54-a210-2f724edbc531
follow me on BLUE SKY BREAKOUT
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM